Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Dementia Due to Alzheimer's Disease”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Study completedNCT04971733
What this trial is testing

Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eisai Inc. 8
Early research (Phase 1)Study completedNCT03019536
What this trial is testing

LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 22
Testing effectiveness (Phase 2)UnknownNCT04388982
What this trial is testing

The Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ruijin Hospital 9
Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Early research (Phase 1)Study completedNCT02624778
What this trial is testing

LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 61
Testing effectiveness (Phase 2)UnknownNCT02833792
What this trial is testing

Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

Who this might be right for
Alzheimer Dementia
Stemedica Cell Technologies, Inc. 40
Not applicableStudy completedNCT06151808
What this trial is testing

Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects

Who this might be right for
Alzheimer Disease
Sinotau Pharmaceutical Group 42
Testing effectiveness (Phase 2)Ended earlyNCT02322021
What this trial is testing

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, Alzheimer Type
Eisai Inc. 70
Testing effectiveness (Phase 2)Study completedNCT03462121
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

Who this might be right for
Mild to Moderate Dementia Due to Alzheimer's DiseaseWith or Without Coexisting Cerebrovascular Disease
Regenera Pharma Ltd 83
Testing effectiveness (Phase 2)Study completedNCT05004688
What this trial is testing

A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD

Who this might be right for
Mild Cognitive ImpairmentMild DementiaModerate Dementia+1 more
Steven E Arnold, MD 15
Large-scale testing (Phase 3)Active Not RecruitingNCT06125951
What this trial is testing

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

Who this might be right for
Dementia ModerateDementia, MildAlzheimer Disease
Actinogen Medical 247
Post-approval studies (Phase 4)WithdrawnNCT01822951
What this trial is testing

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

Who this might be right for
Alzheimer Disease
Ever Neuro Pharma GmbH
Early research (Phase 1)Study completedNCT01837641
What this trial is testing

LY3002813 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 63
Testing effectiveness (Phase 2)UnknownNCT03806478
What this trial is testing

Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
DementiaAlzheimer Disease 1Alzheimer Disease 2+1 more
Aphios 60
Early research (Phase 1)Study completedNCT02754830
What this trial is testing

LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 72
Testing effectiveness (Phase 2)Study completedNCT00976118
What this trial is testing

Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AB Science 34
Not applicableLooking for participantsNCT04124029
What this trial is testing

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Who this might be right for
Mild Traumatic Brain InjuryModerate Traumatic Brain InjuryMild Cognitive Impairment
VA Office of Research and Development 800